000 01050 a2200301 4500
005 20250517071821.0
264 0 _c20160504
008 201605s 0 0 chi d
022 _a1009-2137
024 7 _a10.7534/j.issn.1009-2137.2015.06.043
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Xiao-Ping
245 0 0 _a[Markers for Predicting Response to Hypomethylating Agents in MDS and AML Patients].
_h[electronic resource]
260 _bZhongguo shi yan xue ye xue za zhi
_cDec 2015
300 _a1769-73 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBiomarkers, Tumor
650 0 4 _aBone Marrow
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
650 0 4 _aMethylation
650 0 4 _aMyelodysplastic Syndromes
700 1 _aJing, Yu
700 1 _aLi, Yong-Hui
700 1 _aYu, Li
773 0 _tZhongguo shi yan xue ye xue za zhi
_gvol. 23
_gno. 6
_gp. 1769-73
856 4 0 _uhttps://doi.org/10.7534/j.issn.1009-2137.2015.06.043
_zAvailable from publisher's website
999 _c25579656
_d25579656